Free Trial

BIOLASE (BIOL) News Today

BIOLASE logo
$0.0074 -0.01 (-50.67%)
(As of 12/19/2024 ET)
Biolase Inc (BIOLQ)
Biolase Inc. Faces Bankruptcy Amid Strategic Asset Sale
Sonendo, Inc. Reports Third Quarter 2024 Financial Results
Biolase Inc (BTH0.MU)
What Wall Street expects from Biolase's earnings
Q1 2024 BIOLASE Inc Earnings Call
Biolase Q1 2024 Earnings Preview
Why BIOLASE Shares Are Surging Friday
Q4 2023 BIOLASE Inc Earnings Call
Recap: Biolase Q4 Earnings
Biolase: Q4 Earnings Snapshot
Earnings Preview For Biolase
Maxim Group Reaffirms Their Buy Rating on Biolase (BIOL)
BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
Biolase Stock (NASDAQ:BIOL), Short Interest Report
BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
Get BIOLASE News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

BIOL Media Mentions By Week

BIOL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIOL
News Sentiment

0.00

0.61

Average
Medical
News Sentiment

BIOL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIOL Articles
This Week

0

0

BIOL Articles
Average Week

Get BIOLASE News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BIOL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners